Comprehensive Stock Comparison
Compare Alexander's, Inc. (ALX) vs Welltower Inc. (WELL) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | WELL | 38.0% revenue growth vs ALX's -100.0% |
| Value | ALX | Lower P/E (19.4x vs 73.3x) |
| Stability / Safety | WELL | Beta 0.29 vs ALX's 0.36, lower leverage |
| Dividends | ALX | 7.7% yield; WELL pays no meaningful dividend |
| Momentum (1Y) | WELL | +36.8% vs ALX's +17.9% |
| Efficiency (ROA) | ALX | 2.5% ROA vs WELL's 1.4% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Alexander's is a specialized real estate investment trust that owns and operates premier office and retail properties in prime New York City locations. It generates revenue primarily through long-term leases — with office space contributing roughly 70% and retail about 30% of rental income — along with property management fees. Its competitive advantage lies in its irreplaceable portfolio of trophy properties in Manhattan's most desirable locations, particularly its flagship 731 Lexington Avenue building.
Welltower is a healthcare-focused real estate investment trust that owns and invests in seniors housing communities, post-acute care facilities, and outpatient medical properties. It generates revenue primarily through rental income from its healthcare real estate portfolio — with seniors housing contributing roughly 60% of net operating income, outpatient medical properties about 25%, and post-acute care facilities the remainder. The company's competitive advantage lies in its scale and strategic partnerships with leading healthcare operators, creating a diversified portfolio concentrated in high-growth markets across the U.S., Canada, and the U.K.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
WELL leads in 4 of 6 categories (Financial Metrics, Total Returns). ALX leads in 1 (Valuation Metrics). 1 tied.
Financial Metrics (TTM)
WELL and ALX operate at a comparable scale, with $10.8B and $0 in trailing revenue. On growth, WELL holds the edge at +46.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ALXAlexander's, Inc. | WELLWelltower Inc. |
|---|---|---|
| RevenueTrailing 12 months | $0 | $10.8B |
| EBITDAEarnings before interest/tax | -$35M | $2.6B |
| Net IncomeAfter-tax profit | $28M | $934M |
| Free Cash FlowCash after capex | $73M | $2.1B |
| Gross MarginGross profit ÷ Revenue | — | +20.9% |
| Operating MarginEBIT ÷ Revenue | — | +4.9% |
| Net MarginNet income ÷ Revenue | — | +8.6% |
| FCF MarginFCF ÷ Revenue | — | +19.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.9% | +46.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -68.6% | -26.3% |
Valuation Metrics
At 42.7x trailing earnings, ALX trades at a 71% valuation discount to WELL's 149.0x P/E.
| Metric | ALXAlexander's, Inc. | WELLWelltower Inc. |
|---|---|---|
| Market CapShares × price | $1.2B | $144.3B |
| Enterprise ValueMkt cap + debt − cash | $1.9B | $142.0B |
| Trailing P/EPrice ÷ TTM EPS | 42.66x | 149.01x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.42x | 73.28x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 54.40x |
| Price / SalesMarket cap ÷ Revenue | — | 13.31x |
| Price / BookPrice ÷ Book value/share | 11.04x | 3.26x |
| Price / FCFMarket cap ÷ FCF | 16.32x | 50.06x |
Profitability & Efficiency
ALX delivers a 25.9% return on equity — every $100 of shareholder capital generates $26 in annual profit, vs $2 for WELL. WELL carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to ALX's 7.98x. On the Piotroski fundamental quality scale (0–9), WELL scores 5/9 vs ALX's 4/9, reflecting solid financial health.
| Metric | ALXAlexander's, Inc. | WELLWelltower Inc. |
|---|---|---|
| ROE (TTM)Return on equity | +25.9% | +2.2% |
| ROA (TTM)Return on assets | +2.5% | +1.4% |
| ROICReturn on invested capital | — | +0.9% |
| ROCEReturn on capital employed | — | +0.9% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 |
| Debt / EquityFinancial leverage | 7.98x | 0.07x |
| Net DebtTotal debt minus cash | -$128M | -$2.2B |
| Cash & Equiv.Liquid assets | $128M | $5.0B |
| Total DebtShort + long-term debt | $871M | $2.8B |
| Interest CoverageEBIT ÷ Interest expense | — | 0.81x |
Total Returns (with DRIP)
A $10,000 investment in WELL five years ago would be worth $32,119 today (with dividends reinvested), compared to $11,690 for ALX. Over the past 12 months, WELL leads with a +36.8% total return vs ALX's +17.9%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.6% vs ALX's 9.7% — a key indicator of consistent wealth creation.
| Metric | ALXAlexander's, Inc. | WELLWelltower Inc. |
|---|---|---|
| YTD ReturnYear-to-date | +9.3% | +11.2% |
| 1-Year ReturnPast 12 months | +17.9% | +36.8% |
| 3-Year ReturnCumulative with dividends | +31.8% | +190.2% |
| 5-Year ReturnCumulative with dividends | +16.9% | +221.2% |
| 10-Year ReturnCumulative with dividends | +7.1% | +270.5% |
| CAGR (3Y)Annualised 3-year return | +9.7% | +42.6% |
Risk & Volatility
WELL is the less volatile stock with a 0.29 beta — it tends to amplify market swings less than ALX's 0.36 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WELL currently trades 96.1% from its 52-week high vs ALX's 89.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ALXAlexander's, Inc. | WELLWelltower Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.36x | 0.29x |
| 52-Week HighHighest price in past year | $260.84 | $215.56 |
| 52-Week LowLowest price in past year | $189.05 | $130.29 |
| % of 52W HighCurrent price vs 52-week peak | +89.9% | +96.1% |
| RSI (14)Momentum oscillator 0–100 | 55.5 | 69.0 |
| Avg Volume (50D)Average daily shares traded | 80K | 2.5M |
Analyst Outlook
Wall Street rates ALX as "Buy" and WELL as "Buy". Consensus price targets imply 6.9% upside for WELL (target: $221) vs -46.7% for ALX (target: $125). ALX is the only dividend payer here at 7.67% yield — a key consideration for income-focused portfolios.
| Metric | ALXAlexander's, Inc. | WELLWelltower Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $125.00 | $221.45 |
| # AnalystsCovering analysts | 2 | 34 |
| Dividend YieldAnnual dividend ÷ price | +7.7% | — |
| Dividend StreakConsecutive years of raises | 0 | 1 |
| Dividend / ShareAnnual DPS | $18.00 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Mar 20 | Feb 26 | Change |
|---|---|---|---|
| Alexander's, Inc. (ALX) | 100 | 79.7 | -20.3% |
| Welltower Inc. (WELL) | 100 | 249.04 | +149.0% |
Welltower Inc. (WELL) returned +221% over 5 years vs Alexander's, Inc. (ALX)'s +17%. A $10,000 investment in WELL 5 years ago would be worth $32,119 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Alexander's, Inc. (ALX) | $227M | $0.00 | -100.0% |
| Welltower Inc. (WELL) | $4.3B | $10.8B | +154.9% |
Alexander's, Inc.'s revenue grew from $227M (2016) to $0M (2025) — a -100.0% CAGR. Welltower Inc.'s revenue grew from $4.3B (2016) to $10.8B (2025) — a 11.0% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Alexander's, Inc. (ALX) | 38.1% | 19.2% | -49.6% |
| Welltower Inc. (WELL) | 25.4% | 8.6% | -65.9% |
Welltower Inc.'s net margin went from 25% (2016) to 9% (2025).
Chart 4P/E Ratio History — 9 Years
| Stock | 2017 | 2025 | Change |
|---|---|---|---|
| Alexander's, Inc. (ALX) | 25.1 | 39.6 | +57.8% |
| Welltower Inc. (WELL) | 50.6 | 133.5 | +163.8% |
Alexander's, Inc. has traded in a 10x–80x P/E range over 9 years; current trailing P/E is ~43x. Welltower Inc. has traded in a 27x–219x P/E range over 9 years; current trailing P/E is ~149x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Alexander's, Inc. (ALX) | 16.91 | 5.5 | -67.5% |
| Welltower Inc. (WELL) | 2.81 | 1.39 | -50.5% |
Alexander's, Inc.'s EPS grew from $16.91 (2016) to $5.50 (2025) — a -12% CAGR. Welltower Inc.'s EPS grew from $2.81 (2016) to $1.39 (2025) — a -8% CAGR.
Chart 6Free Cash Flow — 5 Years
Alexander's, Inc. generated $73M FCF in 2025 (-38% vs 2021). Welltower Inc. generated $3B FCF in 2025 (+129% vs 2021).
ALX vs WELL: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is ALX or WELL a better buy right now?
Alexander's, Inc. (ALX) offers the better valuation at 42.7x trailing P/E (19.4x forward), making it the more compelling value choice. Analysts rate Alexander's, Inc. (ALX) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ALX or WELL?
On trailing P/E, Alexander's, Inc. (ALX) is the cheapest at 42.7x versus Welltower Inc. at 149.0x. On forward P/E, Alexander's, Inc. is actually cheaper at 19.4x.
03Which is the better long-term investment — ALX or WELL?
Over the past 5 years, Welltower Inc. (WELL) delivered a total return of +221.2%, compared to +16.9% for Alexander's, Inc. (ALX). A $10,000 investment in WELL five years ago would be worth approximately $32K today (assuming dividends reinvested). Over 10 years, the gap is even starker: WELL returned +270.5% versus ALX's +7.1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ALX or WELL?
By beta (market sensitivity over 5 years), Welltower Inc. (WELL) is the lower-risk stock at 0.29β versus Alexander's, Inc.'s 0.36β — meaning ALX is approximately 25% more volatile than WELL relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 7% versus 8% for Alexander's, Inc. — giving it more financial flexibility in a downturn.
05Which has better profit margins — ALX or WELL?
Welltower Inc. (WELL) is the more profitable company, earning 8.6% net margin versus 0.0% for Alexander's, Inc. — meaning it keeps 8.6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WELL leads at 4.9% versus 0.0% for ALX. At the gross margin level — before operating expenses — WELL leads at 20.9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is ALX or WELL more undervalued right now?
On forward earnings alone, Alexander's, Inc. (ALX) trades at 19.4x forward P/E versus 73.3x for Welltower Inc. — 53.9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WELL: 6.9% to $221.45.
07Which pays a better dividend — ALX or WELL?
In this comparison, ALX (7.7% yield) pays a dividend. WELL does not pay a meaningful dividend and should not be held primarily for income.
08Is ALX or WELL better for a retirement portfolio?
For long-horizon retirement investors, Alexander's, Inc. (ALX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.36), 7.7% yield). Both have compounded well over 10 years (ALX: +7.1%, WELL: +270.5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between ALX and WELL?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: ALX is a small-cap income-oriented stock; WELL is a mid-cap quality compounder stock. ALX pays a dividend while WELL does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.